Press Releases
January 7, 2026
SEALSQ to Demonstrate Its Post-Quantum Technology in Robotics With WISeRobot.ch’s First Proof of Concept at a Davos Roundtable
Indeterminate
GlobeNewswire, Inc.
January 2, 2026
To His Excellency Mr. Guy Parmelin, President of the Swiss Confederation
Gov't Institution
President of Azerbaijan
Owner: Azerbaijani Government
January 7, 2026
Trends and Demand in Thermoformed Trays Market 2025-35
Indeterminate
GlobeNewswire, Inc.
January 6, 2026
GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N
Indeterminate
GlobeNewswire, Inc.
December 18, 2025
Pharmaceutical Bottles Market Report for Packaging Companies
Indeterminate
GlobeNewswire, Inc.
December 17, 2025
Medical Second Opinion Market to Reach US$12.7B by 2031 at 14.8% CAGR, North America Leads with 45%
Neutral
EIN Presswire
January 6, 2026
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
Indeterminate
GlobeNewswire, Inc.
December 22, 2025
Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13
Indeterminate
GlobeNewswire, Inc.
December 21, 2025
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
Indeterminate
GlobeNewswire, Inc.
December 22, 2025
Frozen Yogurt Market Set to Reach USD 11.53 Billion by 2035, Driven by Health Trends and Flavor Innovation
Indeterminate
GlobeNewswire, Inc.
December 10, 2025
Medical Devices Market Size Worth USD 1,209.42 Bn by 2035 Fueled by Advances in Diagnostic Technologies
Indeterminate
GlobeNewswire, Inc.
December 19, 2025
Generic Pharmaceuticals Contract Manufacturing Market to Reach USD 143.22 Billion by 2035, Driven by Demand for Affordable Therapies
Indeterminate
GlobeNewswire, Inc.
January 5, 2026
Mainz Biomed Provides Review of 2025 Highlights
Indeterminate
GlobeNewswire, Inc.
January 5, 2026
Idorsia’s daridorexant in women during menopausal transition age with insomnia
Indeterminate
GlobeNewswire, Inc.
December 18, 2025
Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
Indeterminate
GlobeNewswire, Inc.
December 18, 2025
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
Indeterminate
GlobeNewswire, Inc.